Evidence of intrauterine device insertion by nurses in Primary Health Care: an integrative review / Evidencias de inserción de dispositivos intrauterinos por parte de enfermeros en Atención Primaria de Salud: revisión integradora / Evidências da inserção de dispositivo intrauterino por enfermeiros na Atenção Primária à Saúde: revisão integrativa

ABSTRACT Objectives: to synthesize and analyze evidence on intrauterine device insertion by nurses in Primary Health Care. Methods: an integrative review, carried out in the BDENF, CINAHL, LILACS, SciELO, Scopus, PubMed and Web of Science databases in June 2022, delimiting the period from 1960 to 2022. Results: 141 articles were identified in the initial search, and 10 studies made up the final sample. Four (40%) were developed in the United States and one (10%) in Brazil, with publications from 1979 to 2021. The findings were grouped into three categories: Nurse training to insert an intrauterine device; Nurses' competency to insert an intrauterine device; and Women's access to intrauterine devices. Conclusions: nurse theoretical and practical training is a prominent element, consolidated in the favorable outcomes of insertions performed by nurses and satisfaction among women, a practice that has expanded access to the contraceptive method in Primary Health Care.

RESUMEN Objetivos: sintetizar y analizar la evidencia sobre la inserción de dispositivos intrauterinos por parte de enfermeras en la Atención Primaria de Salud. Métodos: revisión integrativa, realizada en las bases de datos BDENF, CINAHL, LILACS, SciELO, Scopus, PubMed y Web of Science en junio de 2022, delimitando el período de 1960 a 2022. Resultados: se identificaron 141 artículos en la búsqueda inicial y 10 publicaciones conformaron la muestra final. Cuatro (40%) fueron desarrollados en Estados Unidos y uno (10%) en Brasil, con publicaciones de 1979 a 2021. Los hallazgos se agruparon en tres categorías: Capacitación de enfermeras para insertar un dispositivo intrauterino; Competencia de las enfermeras para insertar un dispositivo intrauterino; y Acceso de las mujeres a los dispositivos intrauterinos. Conclusiones: la formación teórica y práctica de los enfermeros es un elemento destacado, consolidado en los resultados favorables de las inserciones realizadas por los enfermeros y la satisfacción de las mujeres, práctica que ha ampliado el acceso al método anticonceptivo en la Atención Primaria de Salud.

RESUMO Objetivos: sintetizar e analisar as evidências da inserção de dispositivo intrauterino por enfermeiros na Atenção Primária à Saúde. Métodos: revisão integrativa, realizada nas bases de dados BDENF, CINAHL, LILACS, SciELO, Scopus, PubMed e Web of Science em junho de 2022, delimitando-se o período de 1960 a 2022. Resultados: identificaram-se 141 artigos na busca inicial, e 10 publicações compuseram a amostra final. Quatro (40%) foram desenvolvidos nos Estados Unidos e um (10%) no Brasil, sendo publicações de 1979 a 2021. Os achados foram agrupados em três categorias: Treinamento dos enfermeiros para inserção de dispositivo intrauterino; Competência dos enfermeiros para inserção de dispositivo intrauterino; e Acesso das mulheres aos dispositivos intrauterinos. Conclusões: o treinamento teórico e prático dos enfermeiros é um elemento de destaque, consolidado nos desfechos favoráveis das inserções realizadas por enfermeiros e satisfação entre as mulheres, prática que tem ampliado o acesso ao método contraceptivo na Atenção Primária à Saúde.

Sports gynecology: a new way to improve female athletes care and performance / Ginecología deportiva: una nueva forma de optimizar atención y el rendimiento de la deportist / Ginecologia do esporte: uma nova maneira de otimizar o cuidado e a performance da mulher atleta

ABSTRACT Introduction: Female participation in sports has reached a milestone in 1972 when a constitutional amendment was implemented to ensure equal opportunities for men and women. Since then, the percentage of participants in competitive sports has grown. In this context became necessary to understand menstrual cycle, contraceptive use, and its individual responses. Objective: To investigate menstrual cycle characteristics, physical and mood symptoms related to vaginal bleeding, and contraceptives used by Brazilian Olympic athletes. Also, to assess if these athletes relate that vaginal bleeding influences sportive performance, how they manage it and what can be changed to improve their health care and sportive performance. Additionally, we propose specialized female care by a gynaecologist specialized in sports medicine. Methods: Descriptive observational study was conducted from July to August 2016 and included 118 Brazilian Olympic female athletes, in menacme. The athletes completed a self-administered online questionnaire, adapted from Pre-Participation Gynaecological Examination of female athletes. Results: Participants practiced 28 different sports, mean age 27 ± 4.7 years. For 66% it was their first participation in an Olympic Game. Most used contraceptives (54%), mainly oral (61%). Most (76%) believed that vaginal bleeding influenced sports performance, and 63% preferred to compete after bleeding cessation. Fifty-eight percent would compete at preferred time of their cycle. Anxiety symptoms, bloating, increased appetite, depression, and dysmenorrhea were indicated by 52%. Among these, 49% reported that these symptoms deteriorated their sportive performance. Conclusion: Most in their first Olympic participation, Brazilian athletes used hormone contraceptives, mainly oral ones to manage and adapt their vaginal bleeding to the competition calendar because most of them referred those physical and mood symptoms deteriorated their sportive performance. The presence of a Sportive Gynaecologist as part of the Olympic Medical Staff highlighted the female athletes issues and helped them to improve sportive performance. Level of Evidence IV; Cross-sectional observational study

RESUMEN Introducción: La participación femenina en deportes alcanzó un hito en 1972, cuando se implementó una reforma constitucional para garantizar igualdad de oportunidades entre hombres y mujeres. Desde entonces, el porcentaje de participantes en deportes competitivos ha crecido. En este contexto, se hizo necesario comprender el ciclo menstrual, el uso de anticonceptivos y sus respuestas individuales. Objetivo: Investigar características del ciclo menstrual, síntomas físicos, estado de ánimo, quejas relacionadas con el sangrado vaginal y los métodos anticonceptivos utilizados por atletas olímpicas brasileñas. Evaluar si estas deportistas perciben influencia del sangrado vaginal en el rendimiento deportivo, cómo lo controlan y qué se puede cambiar para mejorar. Además, ofrecemos atención especializada por una ginecóloga especialista en medicina deportiva. Métodos: Estudio observacional, descriptivo, realizado de julio a agosto de 2016, que incluyó 118 atletas olímpicas brasileñas, en menacme. Las atletas respondieron un cuestionario en línea autoadministrado y adaptado titulado "Examen ginecológico previo a la participación". Resultados: Practicaban 28 deportes diferentes, con edad media = 27 ± 4,7 años. Para 66%, era su primera participación en un juego olímpico. Anticonceptivos usados r54%), principalmente orales (61%). La mayoría (76%) cree que el sangrado vaginal influye en el rendimiento deportivo y 63% prefirió competir después del. El 58% de los atletas competiría en su momento preferido de su ciclo. Los síntomas de ansiedad, hinchazón, aumento del apetito, depresión y dismenorrea fueron indicados por el 52%. Entre estas, 49% deterioró su rendimiento deportivo. Conclusión: En su primera participación olímpica, las atletas brasileñas utilizaron anticonceptivos hormonales, principalmente orales, para controlar y adaptar el sangrado vaginal al calendario de competición, ya que la mayoría relató que los síntomas físicos y anímicos perjudicaban su desempeño deportivo. La presencia de una Ginecóloga Deportiva como parte del Equipo Médico Olímpico destacó los problemas de las atletas y las ayudó a mejorar su rendimiento. Nivel de Evidencia IV; Estudio Observacional.

RESUMO Introdução: A participação feminina no esporte teve um marco importante em 1972, quando uma emenda constitucional foi implementada para garantir a igualdade de oportunidades para homens e mulheres. Desde então, o percentual de participantes em esportes competitivos tem crescido. Nesse contexto tornou-se necessário compreender sobre ciclo menstrual, uso de anticoncepcionais e suas respostas individuais. Objetivo: Investigar características do ciclo menstrual, sintomas físicos e de humor, queixas relacionadas ao sangramento vaginal e métodos contraceptivos usados por atletas olímpicas brasileiras. Avaliar se percebem influência do sangramento vaginal no desempenho esportivo, como elas o controlam e o que pode ser mudado para melhorar seus cuidados e desempenho esportivo. Além disso, propõe-se atendimento específico por ginecologista especializada em medicina esportiva. Métodos: Estudo observacional, descritivo, realizado de julho a agosto de 2016 que incluiu 118 atletas olímpicas brasileiras, na menacme. As atletas responderam a um questionário online autoaplicável e adaptado intitulado "Pre-Participation Gynaecological Examination". Resultados: As participantes praticavam 28 esportes diferentes, com média de idade = 27 ± 4,7 anos. Para 66%, foi a primeira participação em um evento olímpico. A maioria usava anticoncepcional (54%), principalmente oral (61%). A maioria (76%) acredita que o sangramento vaginal influencia o desempenho esportivo e 63% preferiam competir após o mesmo. 58% das atletas competiriam no momento preferido de seu ciclo. Sintomas de ansiedade, distensão abdominal, aumento do apetite, depressão e dismenorreia foram indicados por 52%. Entre esses, 49% deterioraram o desempenho esportivo. Conclusão: Em sua primeira participação olímpica, as atletas brasileiras utilizaram anticoncepcionais hormonais, principalmente orais, para controlar e adaptar o sangramento vaginal ao calendário de competição, pois a maioria referiu que os sintomas físicos e de humor prejudicaram o desempenho esportivo. A presença de uma Ginecologista Esportiva como parte da Equipe Médica Olímpica destacou os problemas das atletas femininas e as ajudou a melhorar o desempenho esportivo. Nível de Evidência IV; Estudo Observacional.

Interrupciones voluntarias del embarazo recurrentes. Estudio de prevalencia y exploración de factores asociados. Antioquia, Colombia, 2015 - 2021 / Recurrent voluntary termination of pregnancy. Prevalence study and exploration of associated factors. Antioquia, Colombia, 2015 ­ 2021

Objetivos: Describir la prevalencia de las interrupciones voluntarias del embarazo (IVE) recurrentes y efectuar una exploración de los factores asociados a esta. Materiales y métodos: Estudio de corte trasversal descriptivo, en el que se incluyeron mujeres atendidas entre 2015 y 2021 en cinco sedes, en el Departamento de Antioquia, de una Institución que promueve la atención en salud sexual y reproductiva (SSR) en Colombia. Se midieron variables sociodemográficas, de SSR, así como la realización de IVE recurrente, tipo de procedimiento utilizado en la primera IVE, y método de anticoncepción elegido posterior a esta. Se presenta la prevalencia de período de aborto recurrente global y por año. Se hace exploración de los factores asociados por medio de análisis multivariado. Se obtuvo aval del comité de investigación de la institución. Resultados: Se incluyó un total de 20.423 mujeres. La prevalencia de IVE recurrente fue del 4,07 % (n = 831) en todo el período, y varió del 2,3 al 6 % en los 6 años. El método más utilizado para la IVE recurrente fue inducción farmacológica (48,50 %). Después de la primera IVE, el 69,81 % de las mujeres utilizó métodos anticonceptivos clasificados como "muy efectivos", según la Organización Mundial de la Salud. Se identificaron como factores de riesgo de la IVE recurrente pertenecer al régimen de aseguramiento subsidiado por el Estado (Odds ratio ajustado (ORa) = 1,35; IC 95 %: 1,05-1,72) y haber tenido dos o más gestaciones (ORa = 1,23; IC 95 %: 1,06 - 1,44). Como factores protectores se identificaron: contratación del servicio de IVE bajo modalidad de pago de bolsillo (ORa = 0,71; IC 95 %: 0,61-0,82), el antecedente de IVE tardía (ORa = 0,30; IC 95 %: 0,11-0,81), y la elección del implante subdérmico posterior al primer aborto primer aborto como (ORa =0,64; IC 95 %: 0,49 - 0,83). Conclusiones: La prevalencia de IVE recurrente posiblemente está incrementando. Se requieren estudios prospectivos que evalúen si existe una tendencia al incremento y que verifiquen posibles hipótesis de asociación que surgen de este trabajo.

Objectives: To describe the prevalence of recurrent voluntary termination of pregnancy (VTP) and to explore associated factors. Material and methods: Descriptive, cross-sectional cohort study which included women seen between 2015 and 2021 in five sites of an institution located in the Department of Antioquia which promotes sexual and reproductive health (SRH) care in Colombia. Measured variables included sociodemographics, SRH, recurrent performance of VTP, type of procedure used in the first VTP and contraception method selected afterwards. The prevalence of global and yearly recurrent abortion period is presented. Associated factors were explored using a multivariate analysis. The research committee of the institution approved the study. Results: In total, 20,423 women were included. The prevalence of recurrent VTP was 4.07 % (n = 831) during the entire period, ranging between 2.3 and 6 % over the 7 years. The most commonly used method for recurrent VTP was pharmacological induction (48.50 %). After the first VTP, 69.81 % of women used contraceptive methods classified as "very effective" according to the World Health Organization. The risk factors identified as being associated with recurrent VTP included being part of the state-subsidized health insurance system (adjusted odds ratio [aOR] = 1.35; 95 % CI:1.05-1.72) and having had two or more pregnancies (aOR = 1.23; 95% CI: 1.06 - 1.44). Protective factors were identified and included out-of-pocket payment for VTP service (aOR = 0.71; 95% CI: 0.61-0.82), a history of late VTP (aOR = 0.30; 95% CI: 0.11-0.81), and the selection of a subdermal implant for contraception following the first abortion (sOR = 0.64; 95% CI: 0.49 - 0.83). Conclusions: It is possible that the prevalence of recurrent VTP is increasing. Prospective studies are required in order to determine whether there is a growing trend and to verify potential association hypotheses derived from this work.

Efecto del implante anticonceptivo sub-dérmico de Etonogestrel sobre el peso corporal en mujeres en edad reproductiva

Objetivo: Analizar el efecto sobre el peso corporal de la anticoncepción hormonal continua mediante implante sub-dérmico liberador de etonogestrel (ENG) en mujeres en edad reproductiva atendidas en la consulta de planificación familiar de un hospital venezolano. Métodos: Investigación comparativa, con diseño cuasi experimental, de casos y controles, a etiqueta abierta, y prospectivo; con una muestra intencionada de 60 mujeres separadas para recibir bien sea un implante subdérmico (Implanon NXT®; casos) o un dispositivo intrauterino (DIU) de cobre (T de cobre; controles). Se evaluaron el peso corporal e índice de masa corporal antes y posterior de doce meses del uso del contraceptivo; así como las características demográficas de las usuarias, efectos adversos y efectividad anticonceptiva de cada método. Resultados: Luego de un año con el implante de ENG no se encontraron variaciones significativas respecto a las mediciones iniciales del peso corporal (61,21±8,30 vs. 61,23±9,50, p>0,5) e IMC (25,23±3.89 vs. 25,26 ±4,30; p>0,05); contrariamente, a lo observado entre las usuarias del DIU donde tanto el peso corporal como el IMC tuvieron un aumento significativo (P<0,05). Asimismo, la mayoría de las usuarias se mantuvieron en el mismo rango de peso donde se encontraban al iniciar el método (p<0,001); mientras que la ganancia ponderal fue mayor entre las usuarias del DIU (1,530±2,04 vs. 3,700±3,02; p<0,05). Conclusiones: El implante de ENG no produce aumento del peso corporal luego de 12 meses de uso, con mínimos efectos adversos y alta efectividad contraceptiva.

Aim: To analyse the effect on body weight of continuous hormonal contraception by releasing subdermal implant etonogestrel (ENG) in women of reproductive age treated in the family planning consultation of a Venezuelan hospital. Methods: Comparative and applied research, with quasiexperimental, case-control, open label and prospective design, with an intentional sample of 60 women separated to receive the contraceptive implant (Implanon NXT®; cases) or a cooper intrauterine device (IUD) (Cooper T; controls) was carried out. Body weight and body mass index were evaluated before and after 12 months of contraceptive use; as well as demographic characteristics of users, side effects, and contraceptive effectiveness of each method. Results: After one year with the ENG implant, no significant variations were found with respect to initial measurements of body weight (61.21±8.30 vs. 61.23±9.50, p>0.5) and BMI (25.23±3.89 vs 25.26±4.30; p>0.05); on the contrary, to what was observed among IUD users where both body weight and BMI had a significant increase (P<0.05). Likewise, most users remained in the same weight range as when starting the method (p<0.001); while weight gain was greater among IUD users (1,530±2.04 vs. 3,700±3.02; p<0.05). Conclusions: The ENG implant does not produce an increase in body weight after 12 months of use, with minimal adverse effects and high contraceptive efficacy.

Análise de impacto orçamentário de dispositivos contraceptivos na saúde suplementar brasileira / Budget impact analysis of contraceptive devices on Brazilian supplementary health

Objetivo: Analisar o impacto orçamentário da adoção de dispositivos contraceptivos reversíveis de longa duração em uma operadora de plano de saúde localizada no Sul do Brasil. Especificamente, analisamos a incorporação do implante subdérmico de etonogestrel (Implanon®) como alternativa ao sistema intrauterino de levonorgestrel (DIU Mirena® ou DIU Kyleena®), ao longo de um período de 15 anos. Métodos: Realizamos uma análise do impacto orçamentário incremental, considerando a inclusão gradual do implante subdérmico de etonogestrel. Foram considerados dados de uma operadora de planos de saúde com mais de 600.000 beneficiários. O horizonte temporal de 15 anos permitiu uma avaliação abrangente dos efeitos financeiros. Resultados: Identificamos 5.345 pacientes elegíveis para a utilização de contraceptivos reversíveis de longa duração. No cenário em que somente o sistema intrauterino de levonorgestrel era adotado, projetou-se um impacto orçamentário total de R$ 746.379.857,80 ao longo de 15 anos. No cenário alternativo, com a incorporação gradual do implante subdérmico, o impacto orçamentário total foi calculado em R$ 689.800.196,83. Isso resultou em um impacto orçamentário incremental negativo de -R$ 56.579.660,97 ao longo do período. Conclusão: A análise de impacto orçamentário realizada indica um potencial benefício financeiro ao adotar o implante subdérmico de etonogestrel como alternativa ao sistema intrauterino de levonorgestrel para contracepção. Esse achado sugere possíveis reduções de custos na área de saúde suplementar no Brasil, reforçando a importância de avaliar opções economicamente viáveis.

Objective: To analyze the budgetary impact of the adoption of long-acting reversible contraceptive devices in a health plan operator located in southern Brazil. Specifically, we analyzed the incorporation of the etonogestrel subdermal implant (Implanon®) as an alternative to the levonorgestrel intrauterine system (Mirena® IUD or Kyleena® IUD), over a period of 15 years. Methods: We performed an analysis of the incremental budgetary impact, considering the gradual inclusion of the etonogestrel subdermal implant. Data from a health plan operator with more than 600,000 beneficiaries were considered. The 15-year time horizon allowed for a comprehensive assessment of the financial effects. Results: We identified 5,345 patients eligible for the use of long-acting reversible contraceptives. In the scenario where only the levonorgestrel intrauterine system was adopted, a total budget impact of BRL 746,379,857.80 was projected over 15 years. In the alternative scenario, with the gradual incorporation of the subdermal implant, the total budgetary impact was calculated at BRL 689,800,196.83. This resulted in a negative incremental budgetary impact of -R$56,579,660.97 over the period. Conclusion: The budget impact analysis carried out indicates a potential financial benefit in adopting the etonogestrel subdermal implant as an alternative to the levonorgestrel intrauterine system for contraception. This finding suggests possible cost reductions in the supplementary healthcare area in Brazil, reinforcing the importance of evaluating economically viable options.

O uso de métodos contraceptivos hormonais em pacientes com asma: repercussões clínicas / The use of hormonal contraceptives methods in patients with asthma: clinical repercussions

Objetivo: Analisar o uso dos contraceptivos hormonais em mulheres com asma e a escolha desses métodos contraceptivos para essa população, com avaliação de eventuais repercussões sobre novos episódios de asma e sibilos. Métodos: Foram selecionados estudos longitudinais, ensaios clínicos, revisões sistemáticas e metanálises. As plataformas consultadas foram PubMed, Embase, Cochrane e SciELO, com a utilização dos descritores: "contracepção", "contracepção hormonal", "sistema intrauterino liberador de levonorgestrel" e "asma". Resultados: Dois grandes estudos demonstraram que o uso de contraceptivos hormonais esteve associado à redução do risco de novos episódios de asma. Uma revisão sistemática concluiu que os resultados para o uso de contraceptivos hormonais para mulheres com asma foram mistos, com aumento ou redução dos seguintes riscos: novo episódio de asma e aumento da frequência das crises e dos sibilos. O uso da contracepção hormonal em pacientes obesas portadoras de asma é controverso. Conclusão: Os resultados para o uso de contraceptivos hormonais em mulheres com asma são inconsistentes, com relatos de aumento ou de redução do risco de novos episódios. O uso do método contraceptivo deve ser discutido individualmente, levando-se em consideração outros fatores de risco associados e o desejo da mulher. A paciente deverá ser orientada se houver piora dos sintomas clínicos de asma na vigência do uso de qualquer método contraceptivo hormonal.

Objective: To analyze the use of hormonal contraceptives in women with asthma and the choice of this contraceptive method for this population, evaluating possible repercussions on new episodes of asthma and wheezing. Methods: Longitudinal studies, clinical trials, systematic reviews and meta-analyses were selected. Platforms consulted: PubMed, Embase, Cochrane, SciELO, using the descriptors: "contraception", "hormonal contraception", "levonorgestrel-releasing intrauterine system" and "asthma". Results: Two large studies demonstrated that the use of hormonal contraceptives was associated with a reduced risk of new episodes of asthma. A systematic review concluded that the results for the use of hormonal contraceptives for women with asthma were mixed, with increased or decrease in the following risks: new asthma episodes, increased frequency and wheezing. The use of hormonal contraception in obese patients with asthma is controversial. Conclusion: The results for the use of hormonal contraceptives in women with asthma are inconsistent, with reports of increased or reduced risk of new episodes. The use of the contraceptive method should be discussed individually, taking into account other associated risk factors and the woman's desire. The patient will be advised if there is a worsening of the clinical symptoms of asthma while using any hormonal contraceptive method.

Adherencia y barreras en el uso de anticonceptivos en mujeres adultas jóvenes atendidas en establecimientos de salud del primer nivel de atención, Perú

Introducción: En los países en vías de desarrollo, la existencia de barreras de acceso de las mujeres a la anticoncepción genera baja adherencia al uso de los diferentes métodos anticonceptivos. Objetivo: Describir la adherencia y barreras en el uso los métodos anticonceptivos en una población de mujeres adultas. Metodología: Estudio cuantitativo, observacional, descriptivo de corte trasversal, con una muestra no probabilística de mujeres mayores de 18 años atendidas en un centro de salud de primer nivel, a quienes se aplicó criterios de selección y se obtuvo consentimiento voluntario para su participación. El estudio siguió los principios de Helsinki y contó con la aprobación del Comité de Ética de la Sociedad Peruana de Obstetricia y Ginecología. El instrumento utilizado fue el IRB Study (Barriers to adolescent contraception adherence) con una consistencia Alfa de Cronbach de 0,79. Se usó estadística descriptiva y la prueba exacta de Fisher para el análisis bivariado. Resultados: Participaron 353 mujeres, la edad media fue 24,6 ± 4,2 años. El 65,7 % fueron solteras y 19,5 % convivientes; el 58,4 % refirió nivel de estudios universitarios; el 73,7 % son de religión católica frente al 26,3% de evangélicos. Los métodos más usados fueron el condón masculino con 37,2 % y las píldoras orales con 23%. Los principales obstáculos fueron el temor por los efectos colaterales de los anticonceptivos con 66,2% y el desplazamiento al centro de salud para su control con 23,5 %. Discusión: La edad y la práctica de actividad sexual son factores que estuvieron vinculados a la adherencia de los anticonceptivos. La preocupación por el aumento de peso, sangrado y riesgo para la salud fueron las principales barreras.

Introduction: In developing countries, the existence of barriers to women's access to contraception generates low adherence to the use of different contraceptive methods. Objective: To describe the adherence and barriers in the use of contraceptive methods in a population of adult women. Methods: Quantitative, observational, descriptive, cross-sectional study, with a non-probabilistic sample of women over 18 years of age attended at a first level health center, to whom selection criteria were applied and voluntary consent was obtained for their participation. The study followed the Helsinki principles and was approved by the Ethics Committee of the Peruvian Society of Obstetrics and Gynecology. The instrument used was the IRB Study (Barriers to adolescent contraception adherence) with a Cronbach Alpha consistency of 0.79. Descriptive statistics and Fisher's exact test were used for bivariate analysis. Results: A total of 353 women participated, the mean age was 24.6 ± 4.2 years; 65.7% were single and 19.5% were cohabiting; 58.4% reported university education; 73.7% were Catholic compared to 26.3% Evangelical. Male condoms (37.2%) and oral pills (23%) were the most commonly used methods. Fear of the side effects of contraceptives (66.2%) and travel to the health center for control (23.5%) were the main obstacles. Discussion: Age and sexual activity were factors associated with contraceptive adherence. Concern about weight gain, bleeding and health risk were the main barriers.

Unsupervised Medical Abortions: A Cause for Concern of Safety

Medical abortions have been a national as well as social concern for the society, especially in India. There have been certain laws, acts and amendments that have been designed to promote safe abortions. Despite, the rules in place, there is still need to have more awareness as the women still face difficulties in accessing abortion services. The reasons may include legal hurdles, stigma, financial concerns and many more. Through this article, we would like to emphasize the role of government, medical professionals, health care providers to come together and form more dependable guidelines that may help women to access safer abortions.

El embarazo adolescente: un error o un deseo cumplido / Teenage pregnancies: a mistake or a fulfilled wish

Resumen Antecedentes: En México los embarazos adolescentes son 77 por cada 1,000. De los nacimientos anuales, el 17% son de madres adolescentes, con casi 350,000. Objetivo: Explicar por qué las adolescentes se embarazan a pesar del conocimiento de métodos anticonceptivos. Métodos: Con un estudio exploratorio y observacional, se evaluaron a 300 adolescentes embarazadas de 15 a 19 años, que no tenían antecedentes de consumo de sustancias adictivas y cuyos embarazos no fueron resultado de una violación.. Se aplicó el cuestionario de funcionamiento familiar y una entrevista de los antecedentes sociodemográficos. Resultados: El inicio de vida sexual fue a los 12 años para el 1.7%, de las participantes, a los 13 para el 7.3%, a los 14 para el 18.7%, a los 15 para el 36%, a los 16 para el 19.3% y las restantes (17%) tuvieron un inicio a los 19 años. El 100% manifestó que conocía métodos anticonceptivos, incluyendo la píldora del día siguiente. Conclusiones: El embarazo a temprana edad viene acompañado de mitos sociales e individuales sobre el conocimiento de la sexualidad humana, la anticoncepción y la vida amorosa. El embarazo representa para las jóvenes tener un objeto de amor y obtener un lugar en el mundo y dentro sus familias.

Abstract Background: In Mexico, teenage pregnancy is 77 for every 1,000. In terms of annual births, 17% are from teenage mothers, which are almost 350,000. Objective: To explain why teenage girls get pregnant in spite of knowing about contraceptives. Method: An observational and exploratory study by which 300 pregnant teenage girls between 15 and 19 years old were evaluated, with no history of substance abuse and whose pregnancies were not the result of rape. A questionnaire on family dynamics and an interview about their sociodemographic background were applied. Results: The first sexual intercourse for 1.7% of the participants was at 12 years old; for 7.3%, at 13; for 18.7%, at 14; for 36%, at 15; for 19.3%, at 16, and for the remaining 17%, near 19 years old. All of them (100%) stated they knew about contraceptives, including the morning-after pill. Conclusions: Pregnancies at an early age come with individual and social myths about the knowledge of human sexuality, contraception, and love life. For these young women, a pregnancy represents an object of love and obtaining a place in the world and within their families.

Contracepção em situações especiais / Contraception in special situations

A decisão de escolha do método contraceptivo em situações clínicas especiais é desafiadora tanto para médicos quanto para pacientes. Em parte, isso se deve às contraindicações reais que alguns contraceptivos apresentam. Porém, há uma estreita relação com a falta de conhecimento e medo de muitos profissionais em prescrever métodos que, na realidade, são seguros. A má escolha do método contraceptivo para pacientes portadoras de condições específicas pode levar a diversos desfechos ruins, como piora da condição de base, ocorrência de eventos adversos indesejáveis e preveníveis e ocorrência de gravidez de alto risco indesejada. Dessa forma, foi realizada uma revisão na literatura com o objetivo de auxiliar profissionais médicos na decisão contraceptiva de pacientes portadoras de doenças reumatológicas e musculoesqueléticas, epilepsia, esclerose múltipla, transtornos alimentares, anemia falciforme e obesidade, e que já foram submetidas a cirurgia bariátrica.(AU)

The decision to choose the contraceptive method in special clinical situations is challenging for both physicians and patients. In part, this is due to the real contraindications that some contraceptives present. However, there is a close relationship with the lack of knowledge and fear of many professionals in prescribing methods that are actually safe. The poor choice of contraceptive method in patients with specific conditions can lead to several bad outcomes, such as worsening of the baseline condition, occurrence of undesirable and preventable adverse events and occurrence of an unwanted high-risk pregnancy. Thus, a literature review was carried out in order to assist medical professionals in the contraceptive decision of patients with rheumatological and musculoskeletal diseases, epilepsy, multiple sclerosis, eating disorders, sickle cell anemia, obesity and who have already undergone bariatric surgery.(AU)

Awareness of emergency contraceptive pills among female patients of family planning unit of tertiary care teaching hospital, Rajkot, Gujarat, India

Background: In India, sizeable population of pregnancies are either unplanned or unwanted and thus these pregnancies add to the population burden or the women may resort to pregnancy termination by traditional or harmful methods leading to serious health consequences. Emergency contraception, developed from trials and research during the past 10 years with aim to cut down the occurrence of unwanted and unintended pregnancies and abortion is one most important step being taken to solve the problem. Aims and Objectives: The objectives of the study were to assess the awareness regarding contraception and emergency contraceptive pills among female patients of reproductive age group and to evaluate any association between marital status, type of family and family member as a sister, education, and awareness about contraception and emergency contraceptive pills. Materials and Methods: A cross-sectional study was conducted among women of reproductive age group over a period of 3 months after obtaining written informed consent. Data were collected regarding demographic parameters, knowledge of different contraceptive measures, and emergency contraceptive pills using an anonymous pretested structured questionnaire. Statistical analysis was done using Microsoft Excel sheet and Medcalc software. Results: A total of 253 women were included in the study. Majority of them were married (94.5%), literate (74.7%), belong to joint family (71.5%), having no history of abortion (69.2%), and having sister in their family (76.7%). About 67.2% know contraceptive methods and the most common source of information was a hospital (58.3%). About 15% were aware of emergency contraceptive pills and audio-visual (71%) is the most common source of information. Awareness about contraception was more in literate women and opposite to this awareness about emergency contraceptives pills was more in illiterate women. Those having sister in their family having more knowledge about contraception and emergency contraceptive pills. Conclusions: Awareness about emergency contraceptive pills is very low. Education can play important role either directly or indirectly to create awareness about emergency contraceptive pills.

Salud sexual y reproductiva en exguerrilleras colombianas antes del Acuerdo de Paz y después de este / Sexual and Reproductive Health of Former Colombian Female Guerrillas before and after the Peace Agreement / Saúde sexual e reprodutiva em ex-guerrilheiras colombianas antes e depois do Acordo de Paz

El objetivo de este artículo es describir las experiencias en salud sexual y reproductiva de exguerrilleras de las Fuerzas Armadas Revolucionarias de Colombia-Ejército del Pueblo (fARC-EP) durante el conflicto armado y después de la firma del Acuerdo de Paz. A lo largo de 2018 se realizó un estudio de caso interpretativo a través de observación participante, once entrevistas y dos grupos focales. En las fARC-EP no hubo un enfoque de salud sexual y reproductiva integral ni con perspectiva de género; se privilegió la prevención del embarazo con métodos y sanciones para las mujeres. Debido a su carácter de ejército clandestino, las decisiones no eran tomadas de manera individual, y la autoridad del superior implicaba las relaciones erótico-afectivas, aunque se garantizaba una atención expedita para casos de urgencias. Posterior a la firma del acuerdo, con su consiguiente inserción en el sistema de salud colombiano, se amplían las posibilidades de atención para casos no urgentes, pero persisten las barreras de atención del sistema de salud.

This study examined the sexual and reproductive health statuses of former female guerrillas of the Revolutionary Armed Forces of Colombia-People's Army (fARC-EP) during the armed conflict and after the signing of the peace agreement. During 2018, an interpretive case study was conducted through the participant observation, 11 interviews, and 2 focus groups. In the fARC-EP group, no comprehensive approach to sexual and reproductive health was noted from a gender perspective, but pregnancy prevention using methods and sanctions for women was found to be privileged. Owing to its characteristic as a clandestine army, decisions were not made individually, and the authority of the superior involved erotic-affective relationships, although expedited attention was guaranteed for emergency cases. After the signing of the agreement, with its consequent insertion into the Colombian health system, the possibilities of care for non-urgent cases have been expanded, with the barriers to healthcare being emphasized

O objetivo deste artigo é descrever as experiências em saúde sexual e reprodutiva de ex-guerrilheiras das Forças Armadas Revolucionárias da Colômbia - Exército Popular (fARC-EP) durante o conflito armado e após a assinatura do acordo de paz. Durante o ano de 2018, foi realizado um estudo de caso interpretativo através da observação participante, 11 entrevistas e dois grupos focais. Nas fARC-EP não havia abordagem integral da saúde sexual e reprodutiva ou perspectiva de gênero; privilegiou-se a prevenção da gravidez com métodos e sanções para as mulheres. Por ser um exército clandestino, as decisões não eram tomadas individualmente, e a autoridade do superior implicava relações erótico-afetivas, embora garantisse atendimento ágil em casos de emergência. Após a assinatura do convênio, com sua consequente inserção no sistema de saúde colombiano, ampliam-se as possibilidades de atendimento aos casos não urgentes, mas enfatizam-se as barreiras para o atendimento no sistema de saúde.

Effect of the timing of insertion of postpartum intrauterine contraceptive device (PPIUCD) copper T380A on expulsion rates

Background & objectives: Postpartum intrauterine contraceptive device (PPIUCD) is well accepted and recommended for contraception. However, anxiety at the time of delivery may restrict the acceptance of a PPIUCD for its immediate insertion. So far there is limited evidence to conclude anything concrete on the association between the expulsion rates and the timing of insertion following a vaginal delivery. Thus, this study was undertaken to compare the expulsion rates in immediate and early insertions and their safety and complications. Methods: This prospective comparative study was carried out over 17 months on women delivering vaginally in a tertiary care teaching hospital in South India. A copper device (CuT380A) was inserted using Kelly’s placental forceps either within 10 min of placental delivery (immediate group, n=160) or between 10 min upto 48 h postpartum (early group, n=160). Ultrasound was done before discharge from the hospital. The expulsion rates and any other complications at six-week and three-month follow up were studied. Chi-square test was used to compare the difference in expulsion rates. Results: The expulsion rate was five per cent in the immediate compared to 3.7 per cent in the early group (no significant difference). In ten cases, the device was found to be in the lower uterus upon ultrasound before discharge. These were repositioned. There was no case with perforation, irregular bleeding or infection up to the three-month follow up. Higher age, higher parity, lack of satisfaction and motivation to continue were predictors of expulsion. Interpretation & conclusions: In the present study PPIUCD was found to be safe with overall expulsion in 4.3 per cent. It was marginally, though not significantly, higher in the immediate group.

Cuidados reprodutivos para a pessoa transgênero ­ do planejamento gestacional ao puerpério: uma revisão narrativa / Reproductive care for transgender persons ­ from gestational planning to puerperium: a narrative review

Objetivo: Apesar de 0,69% da população brasileira em idade reprodutiva se identificar como transgênero, os cuidados relacionados ao ciclo gravídico-puerperal e ao planejamento gestacional ainda são desconhecidos pelos profissionais de saúde. Métodos: Esta revisão narrativa avaliou o planejamento gestacional e contracepção; a possibilidade do emprego de técnicas de reprodução assistida segundo as recomendações do Conselho Federal de Medicina no Brasil; e a gestação, pré-natal e puerpério na população transgênero. Resultados: Dos 664 artigos encontrados no PubMed e Embase, 29 foram considerados para a confecção desta revisão. O uso da testosterona por trans masculinos, apesar de promover amenorreia, não é considerado um método contraceptivo. Contraindicações aos métodos hormonais devem seguir as mesmas orientações propostas para as mulheres cisgênero. Cuidados pré-natais não diferem dos habituais, Pessoas transgênero podem desejar amamentar. Conclusão: O desconhecimento das melhores práticas voltadas para o acolhimento e seguimento das pessoas transgênero pode resultar em negligência aos cuidados essenciais durante esse período. O conhecimento e a validação dessas identidades e o preparo das equipes são essenciais para melhorar o acesso dessa população às redes de saúde.

Objective: Although 0.69% of the Brazilian population of reproductive age identify themselves as transgender, care related to the pregnancy-puerperal cycle and pregnancy planning is still unknown to health professionals. Methods: This narrative review assessed pregnancy planning and contraception; the possibility of using Assisted Reproduction Technologies according to the recommendations of the Federal Council of Medicine in Brazil; and pregnancy, prenatal, and puerperium in the transgender population. Results: Of the 664 articles found in PubMed and Embase, 29 were considered for the compilation of this review. The use of testosterone by transgender male, despite promoting amenorrhea, is not considered a contraceptive method. Contraindications to hormonal methods should follow the same guidelines for cisgender women. Prenatal care and delivery should not differ from the usual. Transgender might be able to breastfeed. Conclusion: The lack of knowledge for transgender follow-up may result in neglect of prenatal care. Knowledge and validation of these identities and staff training are essential to improve the access of this population to health networks.

Controversias éticas en la atención del aborto, fertilización in vitro y anticoncepción en la mujer

En relación con los procesos de reproducción, las evidencias científicas de los últimos años y la vasta y mejor información con la que se cuenta para medir y estimar los indicadores de morbilidad y mortalidad en salud reproductiva han llevado a definir nuevas estrategias en el marco del derecho a la salud que tienen las mujeres. Para algunas personas son planteamientos claros, pero para otros no tanto, generando a la luz de los principios de ética controversias que es necesario plantear y, si es posible, resolver. En ese sentido, se ha seleccionado para esta presentación el aborto, la reproducción asistida y la anticoncepción, temas actuales que suscitan opiniones diferentes o contrapuestas de personas o instituciones, no siempre producto de una reflexión, justa, honrada, no ideologizada, buscando el bienestar de las personas. A veces, es el resultado de la satisfacción de un interés personal o institucional.

In relation to reproductive processes, the scientific evidence of recent years and the vast and better information available for measuring and estimating morbidity and mortality indicators in reproductive health have led to the definition of new strategies within the framework of women's right to health. For some people these approaches are clear, but for others they are not so clear, generating controversies in the light of ethical principles that need to be raised and, if possible, resolved. In this sense, we have selected for this presentation abortion, assisted reproduction and contraception, current issues that raise different or opposing opinions of individuals or institutions, not always the product of a reflection, fair, honest, non-ideologized, looking for the welfare of people. Sometimes, it is the result of the satisfaction of a personal or institutional interest.

Contracepção pós-parto e pós-abortamento: um compilado das evidências atuais / Postpartum and post-abortion contraception: a compilation of current evidences

Idealmente, a contracepção deve ser iniciada o mais precocemente possível após o parto ou após o abortamento, permitindo que as mulheres sejam protegidas contra uma gravidez não programada subsequente. O objetivo desta revisão é discutir a contracepção no pós-parto e pós-aborto, por meio da análise de ensaios clínicos e metanálises, além das principais diretrizes internacionais, com ênfase nas indicações e contraindicações, tempo de início do uso dos métodos contraceptivos e possíveis complicações. Nesta revisão não sistemática, são discutidos os principais métodos contraceptivos: dispositivos intrauterinos, métodos somente de progestagênios, métodos hormonais combinados, métodos de barreira, método de amenorreia lactacional e esterilização. O aconselhamento contraceptivo pós-parto deve começar durante o pré-natal e, em pacientes após abortamento, durante a internação hospitalar. Todas as mulheres devem ter acesso a informações claras sobre cada método contraceptivo, e o processo de tomada de decisão deve ser compartilhado com o médico assistente. Idealmente, métodos de contracepção reversíveis de longa duração devem ser priorizados em relação aos outros. Em conjunto, todas as evidências demonstram que o melhor método para cada paciente é aquele que combine altas taxas de segurança com o desejo da paciente de iniciá-lo e mantê-lo pelo tempo que desejar.

Contraception should ideally be started as early as possible after childbirth or abortion to allow women to be protected against a subsequent unplanned pregnancy. The aim of this review is to discuss postpartum and postabortion contraception, through the analysis of clinical trials and meta-analyses, in addition to the main international guidelines, with emphasis on indications and contraindications, time to start contraceptive method and possible complications. In this review, the main contraceptive methods are discussed: intrauterine devices, progestin-only methods, combined hormonal methods, barrier methods, lactational amenorrhea method and sterilization. Postpartum contraceptive counseling should start during prenatal care and during hospital stay in post-abortion patients. All women should have access to clear information about each contraceptive method and the decision-making process must be shared. Ideally, long acting reversible contraception methods should be prioritized over others. Taken together, all the evidence shows that the best method for each patient is the one that combines high safety rates with the patient's desire to start and maintain it for as long as she wants.

Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients

Background: Contraception is the intentional use of artificial methods or other techniques to prevent pregnancy as a consequence of sexual intercourse. Progesterone only injectables are highly effective in preventing in pregnancy as they do not rely on daily usage of contraceptions as such as oral contraceptive pills and barrier methods. Injection depot-medroxyprogesterone acetate (DMPA) is an effective contraceptive method in lactating mother and postabortal patients. Aims and Objectives: The aims of this study were to study utilization pattern, acceptance, effectiveness, and adverse effects of DMPA in postpartum and postabortal women. Materials and Methods: It was a prospective and observational single-center study and was conducted at tertiary care teaching hospital. The data were collected in patient received Inj. DMPA 150 mg intra muscularly immediately after abortion and delivery before discharge. The follow-up was done after administration of DMPA (usually every 3 months). Results: In this study, 56 (53.34%) patients were in the age group of 18–25 years, while 38 (36.19%) patients were 26–35 years whereas 11 (10.47%) were more than 36 years. Out of 105 patients, 12 patients were administered only one injection, 16 patients administered two injections and 16 patients given three injections of DMPA. Common adverse effects of DMPA are irregular bleeding (43.8%), amenorrhea (22.8%), and heavy bleeding (5.7%). Out of 24 patient who developed amenorrhea after injections of DMPA, total 11 patients had amenorrhea after fourth injection, 5 patients after first injection, and 2 patients after second injection of DMPA. Average time for return of fertility after last injection of DMPA was 9 months. Conclusion: DMPA is very effective contraceptive and apart from menstrual troubles that there are no significant major side (weight gain, mood changes, etc.) effects related to its use. DMPA may cause a delay in the return of fertility, the return of fertility takes 7–10 months from date of last injection, but it is completely reversible.

Evaluation of awareness, acceptability, and clinical outcome of postpartum vaginal insertion and intra-cesarean insertion of intrauterine contraceptive device

Background: Post-placental and intra-cesarean insertion of intrauterine contraceptive devices (PPIUCD) is a lucrative family planning method which provides safe, effective reversible, inexpensive, non-hormonal, and long-acting contraception. Aims and Objectives: The objective of the study is to evaluate the postpartum insertion of intrauterine contraceptive device in terms of awareness, acceptance, safety, efficacy, continuation, and removal rate and its complications in both vaginal as well as intra-cesarean section (CS) insertion. Materials and Methods: Prospective observational study conducted in Obstetrics and Gynaecology Department GMERS sola for 6 months. Two thousand and ninety-four pregnant women from labor room who delivered vaginally or by CS during study period were asked regarding their knowledge and acceptability for PPIUCD. Results: Total 2094 women evaluated for awareness and acceptance for PPIUCD. About 68.66% were familiar with the concept with 29.99% giving verbal consent for its insertion. About 60.01% women refused for various reasons. Conclusion: This study shows that PPIUCD insertion is a safe and convenient method which requires more population awareness, counseling, and usage.

Análise da dispensação de pílula do dia seguinte em uma farmácia do município no oeste do estado do Paraná / Analysis of the dispension of the pill of the following day in a pharmacy in the municipality in the west of the state of Paraná / Análisis de la dispensación de la píldora del día siguiente en una farmacia del municipio del oeste del estado de Paraná

pílula contraceptiva de emergência (CE) é chamada pelos médicos de pílula anticoncepcional pós-coito. É um método anticoncepcional de emergência e deve ser tomada até 72 horas após a relação sexual. É adequado para casos de abuso sexual, preservativos rompidos ou falha de outros métodos anticoncepcionais. Sendo assim, o objetivo do presente estudo foi avaliar o perfil da dispensação do contraceptivo de emergência (CE) em uma farmácia comercial localizada em um distrito do município de Assis Chateaubriand no oeste do estado do Paraná. Para o desenvolvimento da pesquisa, foi avaliado a quantidade do medicamento dispensado com o princípio ativo levonorgestrel no período de três meses em uma farmácia de dispensação de medicamentos no distrito de Bragantina, assim como a faixa etária da paciente que utilizou, o seu estado civil e o motivo da compra da pílula. O projeto foi aprovado pelo Comitê de ética sob o número do CAAE: 60509322.3.0000.0109. Os resultados mostraram que no período do desenvolvimento da pesquisa, 10 pacientes fizeram uso da CE, sendo 5 solteiras e 5 casadas, sendo 50%. Quando relatado a idade das pacientes que fazem uso do CE, os resultados foram entre 19 até 41 anos. Quando perguntado para as pacientes se elas faziam uso de outro método contraceptivo e se presente, qual seria este método, os resultados encontrados foram: 40% das mulheres não utilizam outro método contraceptivo e 60% fazem o uso de outro contraceptivo, destes, o percentual foi de 66% que faziam o uso de preservativo e 34% faziam o uso de anticoncepcional. Em relação ao horário pós-coito, isto é, quantas horas após o coito elas procuraram a farmácia para comprar a CE, os resultados encontrados foram de 08 horas até 52 horas. Sendo assim, conclui-se que o estudo possui relevância frente à procura da PDS, no entanto, é de suma importância não esquecer de que a PDS deve ser utilizada somente em casos de emergências e não como uso rotineiro, para isso, existem outros métodos de contraceptivos que podem ser de recurso rotineiro. Neste sentido, mais estudos são necessários para avaliar se a população tem conhecimento sobre o tema, se o farmacêutico está preparado para atendê-los e o porquê da população não se programar melhor para evitar os possíveis "acidentes".

The morning after pill (PDS) is called the post-coital birth control pill by doctors. It is an emergency contraceptive method and must be taken within 72 hours of sexual intercourse. It is suitable for cases of sexual abuse, broken condoms or failure of other contraceptive methods. Therefore, the objective of the present study will be to evaluate the profile of the dispensation of emergency contraceptives (EC) in a pharmacy in the western municipality of the state of Paraná. For the development of the research, the amount of medication dispensed in a period of three months in a drug dispensing pharmacy was evaluated, as well as the age group of the patient who will use it, her marital status and the reason for purchasing the pill. The project was approved by the Ethics Committee under CAAE number: 60509322.3.0000.0109. The results showed that during the research development period, 10 patients used PDS, 5 of them single and 5 married, being 50%. When reporting the age of patients using the morning-after pill, the results ranged from 19 to 41 years. When asked to patients if they used another contraceptive method and, if present, which method this would be, the results found were: 40% of women do not use another contraceptive method and 60% use another contraceptive, of these, the percentage 66% used condoms and 34% used contraceptives. Regarding the post-coital time, that is, how many hours after coitus they looked for the pharmacy to buy the PDS, the results found were from 08 hours to 52 hours. Therefore, it is concluded that care with medication intake becomes more important when it comes to EC, due to its potential risks to the female body, which can have consequences, especially when used excessively and without prior knowledge. Thus, more guidance on the use and its adverse effects, as more studies on the subject are necessary, in order to minimize the damage that PDS can cause in the female organism.

La píldora del día después (PDS) es llamada por los médicos píldora anticonceptiva poscoital. Es un método anticonceptivo de emergencia y debe ser tomada dentro de las 72 horas siguientes a la relación sexual. Está indicada en casos de abuso sexual, rotura del preservativo o fracaso de otros métodos anticonceptivos. Por lo tanto, el objetivo del presente estudio será evaluar el perfil de la dispensación de anticonceptivos de emergencia (AE) en una farmacia del municipio oeste del estado de Paraná. Para el desarrollo de la investigación, se evaluó la cantidad de medicación dispensada en un período de tres meses en una farmacia dispensadora de medicamentos, así como el grupo etario de la paciente que la utilizará, su estado civil y el motivo de compra de la píldora. El proyecto fue aprobado por el Comité de Ética con el número CAAE: 60509322.3.0000.0109. Los resultados mostraron que durante el período de desarrollo de la investigación, 10 pacientes utilizaron la PDS, 5 de ellas solteras y 5 casadas, siendo el 50%. Al informar sobre la edad de las pacientes que utilizaban la píldora del día después, los resultados oscilaron entre 19 y 41 años. Cuando se preguntó a las pacientes si utilizaban otro método anticonceptivo y, en caso afirmativo, cuál sería, los resultados encontrados fueron: 40% de las mujeres no utilizan otro método anticonceptivo y 60% utilizan otro anticonceptivo, de estas, el porcentaje 66% utilizó preservativo y 34% anticonceptivos. En cuanto al tiempo post-coital, es decir, cuántas horas después del coito buscaron la farmacia para comprar la PDS, los resultados encontrados fueron de 08 horas a 52 horas. Por lo tanto, se concluye que el cuidado con la ingesta de medicamentos se vuelve más importante cuando se trata de la AE, debido a sus riesgos potenciales para el organismo femenino, que pueden tener consecuencias, especialmente cuando se usa en exceso y sin conocimiento previo. Por lo tanto, son necesarias más orientaciones sobre el uso y sus efectos adversos, así como más estudios sobre el tema, con el fin de minimizar los daños que la PDS puede causar en el organismo femenino.

Study of Contraceptive Duration Described in the Information Materials of Prescription Drugs Requiring Contraception / 医薬品情報学

Objective: In the instructions for package inserts (PI) of prescription drugs revised in June 2017, the section “persons with reproductive potential” was established under “precautions concerning patients with specific backgrounds.” The description rules associated with contraceptive duration were modified in these. In this study, we investigated descriptions of contraceptive duration in PI that were prepared based on the revised instructions, interview forms (IF), and other proper use materials (PM).Methods: We collected PI, IF, and PM of prescription drugs containing a new active ingredient approved from April 2017 to March 2022 for which the PI were prepared based on the revised instructions and investigated descriptions of PI, contraceptive duration, and its evidence in each information material.Results: Of the 181 drugs studied, 43.1 and 12.7% required females and males to use contraception during the period of drug consumption, respectively. Among these, the ratio of drugs that had descriptions of contraceptive duration were 15.4 and 0% for females and males at PI, respectively; 51.3 and 39.1% for female sand males at IF, respectively. Anticancer drugstended to describe contraceptive duration in the PM rather than PI or IF. For some drugs, there was no description of contraceptive duration in any of the materials. Contraceptive durations ranged from the period of administration of that drug to over a year for females and approximately one week to six months for males. The reasons for these contraceptive durations were diverse.Conclusion: Contraceptive information in the PI based on revised instructions were not sufficient for use by healthcare workers, even when the IF and PM were confirmed. These results suggest that there is a need for standardizing the descriptions, types of materials to be described, and choice of evidence for contraceptive duration.